GlassScriptPhysician profile
Eileen F Hogan
NPI 1962587345
$5,710.42
in general payments reported to CMS, 2019-2025
34 companies · $362 in 2025
The $362 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,812 · 2022: $2,149 · 2023: $705 · 2024: $683 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,750.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $828.59 | 2021-2023 | Rybelsus, Ozempic |
| Medtronic, INC. | $760.26 | 2021-2025 | Minimed 780g |
| Dexcom, INC. | $581.00 | 2021-2024 | Dexcom G6 Transmitter |
| Insulet Corporation | $568.90 | 2021-2025 | Omnipod |
| Sanofi-Aventis U.S. LLC | $477.35 | 2021-2024 | |
| Lilly USA, LLC | $462.80 | 2021-2024 | Jardiance, Mounjaro, Trulicity |
| Abbott Laboratories | $291.45 | 2021-2024 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $201.91 | 2021-2024 | Jardiance |
| Ascensia Diabetes Care US INC. | $179.19 | 2021-2024 | |
| Amgen INC. | $132.47 | 2021-2024 | Prolia, Evenity, Tepezza |
| Corcept Therapeutics | $124.13 | 2021-2023 | Korlym |
| Currax Pharmaceuticals LLC | $123.37 | 2021-2023 | Contrave, Onzetra Xsail |
| Antares Pharma, INC. | $110.10 | 2021-2023 | Xyosted, Nocdurna, Tlando |
| Pfizer INC. | $106.94 | 2021 | |
| Abbvie INC. | $92.64 | 2021-2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $69.59 | 2021-2024 | Afrezza |
| Radius Health, INC. | $59.99 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.49 | 2021-2023 | |
| Recordati_rare_diseases_inc. | $55.92 | 2022-2023 | Isturisa, Signifor Lar |
| Merck Sharp & Dohme LLC | $49.01 | 2021-2023 | Steglatro |
| Renalytix Ai, INC. | $45.90 | 2022-2023 | Kidneyintelx Blood Collection Convenience Kit |
| Intuity Medical INC | $38.98 | 2022 | |
| Eusa Pharma (US) LLC | $37.90 | 2022 | |
| Horizon Therapeutics Plc | $35.16 | 2021 | |
| Amneal Pharmaceuticals LLC | $34.92 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $33.58 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $31.69 | 2021-2022 | |
| Tandem Diabetes Care, INC. | $26.32 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Becton, Dickinson and Company | $17.98 | 2022 | |
| Rgh Enterprises LLC | $17.57 | 2024 | |
| Halozyme INC | $14.73 | 2023 | |
| Novartis Pharmaceuticals Corporation | $14.35 | 2024 | |
| Ibsa Pharma INC. | $13.20 | 2021 | |
| Lifescan, INC. | $13.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eileen Hogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.